INIS
abundance
20%
biopsy
10%
comparative evaluations
20%
control
30%
defects
30%
diabetes mellitus
10%
doses
10%
glucose
20%
in vivo
10%
insulin
100%
kinases
20%
levels
10%
muscles
40%
obesity
10%
ovaries
80%
receptors
50%
steady-state conditions
10%
substrates
30%
weight
10%
women
30%
Medicine and Dentistry
Age
10%
Ethinylestradiol Plus Megestrol Acetate
10%
Glucose
20%
Insulin Receptor
20%
Insulin Receptor Substrate 1
20%
Insulin Receptor Substrate 2
10%
Insulin Signaling
10%
Maturity Onset Diabetes of the Young
10%
Muscle
10%
Muscle Biopsy
10%
Obesity
10%
Phosphoinositide 3-Kinase
20%
Polycystic Ovary Syndrome
80%
Skeletal Muscle
30%
Steady State
10%
Woman
30%
Pharmacology, Toxicology and Pharmaceutical Science
Ethinylestradiol Plus Megestrol Acetate
10%
Glucose
20%
Insulin
40%
Insulin Receptor
20%
Insulin Receptor Substrate 1
20%
Insulin Receptor Substrate 2
10%
Non Insulin Dependent Diabetes Mellitus
10%
Obesity
10%
Ovary Polycystic Disease
80%
Phosphatidylinositol 3 Kinase
20%
Biochemistry, Genetics and Molecular Biology
Age
10%
Dose
10%
Glucose
20%
Insulin
30%
Insulin Level
10%
Insulin Receptor
50%
Insulin Signaling
10%
Kinase
20%
Phosphatidylinositol
20%
Skeletal Muscle
30%
Steady State
10%
Weight
10%